Cargando…
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
BACKGROUND: Data on the prevalence of dyslipidemia and attainment of goal/normal lipid levels in a Swedish population are scarce. The objective of this study is to estimate the prevalence of dyslipidemia and attainment of goal/normal lipid levels in patients treated with lipid modifying therapy (LMT...
Autores principales: | Pettersson, Billie, Ambegaonkar, Baishali, Sazonov, Vasilisa, Martinell, Mats, Stålhammar, Jan, Wändell, Per |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009647/ https://www.ncbi.nlm.nih.gov/pubmed/21114824 http://dx.doi.org/10.1186/1471-2458-10-737 |
Ejemplares similares
-
Mixed dyslipidemias in primary care patients in France
por: Laforest, Laurent, et al.
Publicado: (2012) -
Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
por: Al Sifri, Saud N., et al.
Publicado: (2014) -
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline
por: Journath, Gunilla, et al.
Publicado: (2017) -
Do acute coronary events affect lipid management and cholesterol goal attainment in Germany?: Results from the Dyslipidemia International study II
por: Gitt, Anselm K., et al.
Publicado: (2018) -
Automated data extraction—A feasible way to construct patient registers of primary care utilization
por: Martinell, Mats, et al.
Publicado: (2012)